These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9869915)

  • 1. Sirolimus, a potent new immunosuppressive drug for organ transplantation.
    Stepkowski SM
    Ann Transplant; 1996; 1(3):19-25. PubMed ID: 9869915
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus for solid organ transplantation in children.
    Gupta P; Kaufman S; Fishbein TM
    Pediatr Transplant; 2005 Jun; 9(3):269-76. PubMed ID: 15910380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging strategies for the clinical application of rapamycin.
    Kahan BD
    Clin Biochem; 1998 Jul; 31(5):341-4. PubMed ID: 9721432
    [No Abstract]   [Full Text] [Related]  

  • 4. [Everolimus].
    Michels G; Hoppe UC
    Dtsch Med Wochenschr; 2005 Oct; 130(40):2263-5. PubMed ID: 16208601
    [No Abstract]   [Full Text] [Related]  

  • 5. Sirolimus, a new potent immunosuppressant agent for refractory cardiac transplantation rejection: two case reports.
    Haddad H; MacNeil DM; Howlett J; O'Neill B
    Can J Cardiol; 2000 Feb; 16(2):221-4. PubMed ID: 10694593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations].
    Arns W; Budde K; Eitner F; Gwinner W; Hugo C; Pressmar K; Weimann A; Witzke O
    Dtsch Med Wochenschr; 2011 Dec; 136(49):2554-9. PubMed ID: 22131077
    [No Abstract]   [Full Text] [Related]  

  • 7. Considerations in sirolimus use in the early and late post-transplant periods.
    Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
    Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of sirolimus in kidney transplantation.
    Podbielski J; Schoenberg L
    Prog Transplant; 2001 Mar; 11(1):29-32. PubMed ID: 11357554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirolimus. AY 22989, NSC 226080, NSC 606698, rapamycin, Rapamune.
    Drugs R D; 1999 Jan; 1(1):100-7. PubMed ID: 10566001
    [No Abstract]   [Full Text] [Related]  

  • 10. Steroid immunosuppression in kidney transplantation: a passing era.
    Schulak JA
    J Surg Res; 2004 Mar; 117(1):154-62. PubMed ID: 15013726
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunosuppression with sirolimus so donor kidneys survive longer].
    MMW Fortschr Med; 2004 Aug; 146(31-32):46-7. PubMed ID: 15529711
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.
    Ahya VN; McShane PJ; Baz MA; Valentine VG; Arcasoy SM; Love RB; Seethamraju H; Garrity E; Alex CG; Bag R; DeOliveira NC; Vigneswaran WT; Charbeneau J; Krishnan JA; Durazo-Arvizu R; Norwick L; Bhorade S
    J Heart Lung Transplant; 2011 Feb; 30(2):175-81. PubMed ID: 20947384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of immunosuppressive therapy in organ transplantation.
    MacGregor MS; Bradley JA
    Br J Hosp Med; 1995 Sep 20-Oct 3; 54(6):276-84. PubMed ID: 8542176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of sirolimus in renal transplantation.
    Halleck F; Duerr M; Waiser J; Huber L; Matz M; Brakemeier S; Liefeldt L; Neumayer HH; Budde K
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1337-56. PubMed ID: 22928953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunosuppression in organ transplantation. New substances and therapeutic approaches].
    Wonigeit K
    Internist (Berl); 1996 Mar; 37(3):229-39. PubMed ID: 8919940
    [No Abstract]   [Full Text] [Related]  

  • 16. Late acute cardiac allograft rejection: new therapeutic options?
    Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
    Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.
    Cowan PA; Heizer KE
    Nephrol Nurs J; 2000 Dec; 27(6):623-5. PubMed ID: 16649344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional immunosuppression of organ transplants.
    Gruber SA
    Immunol Rev; 1992 Oct; 129():5-30. PubMed ID: 1464421
    [No Abstract]   [Full Text] [Related]  

  • 19. Practical recommendations for the early use of m-TOR inhibitors (sirolimus) in renal transplantation.
    Campistol JM; Cockwell P; Diekmann F; Donati D; Guirado L; Herlenius G; Mousa D; Pratschke J; San Millán JC
    Transpl Int; 2009 Jul; 22(7):681-7. PubMed ID: 19386082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.
    Bhorade S; Ahya VN; Baz MA; Valentine VG; Arcasoy SM; Love RB; Seethamraju H; Alex CG; Bag R; Deoliveira NC; Husain A; Vigneswaran WT; Charbeneau J; Krishnan JA; Durazo-Arvizu R; Norwick L; Garrity E
    Am J Respir Crit Care Med; 2011 Feb; 183(3):379-87. PubMed ID: 20833822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.